Status:
UNKNOWN
Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation
Lead Sponsor:
The Affiliated Hospital of Qingdao University
Conditions:
Liver Fibrosis After Liver Transplantation
Multiparameter Magnetic Resonance Imaging
Eligibility:
All Genders
18-85 years
Brief Summary
It is an open label observation clinical trial, all participants are liver transplant patients. The investigators deem to make a better criteria for assessing liver fibrosis after liver transplantatio...
Detailed Description
We collected patients aged 18 to 85 who had undergone liver transplantation. At the same time, all patients underwent liver biopsy or ultrasonic transient elastography after MRI. People who were aller...
Eligibility Criteria
Inclusion
- Subjects aged 18 -85 years
- Patients after liver transplantation
- Patients who are going to undergo liver biopsy or ultrasonic transient elastography
- Patients voluntarily joined the study and signed informed consent
Exclusion
- Patients with tumor
- Patients who are allergic to gadolinium contrast agent
- Patients with contraindications to magnetic resonance imaging
- Patients with severe heart and lung diseases
- Patients who are not suitable for this study according to the researcher's judgment.
Key Trial Info
Start Date :
March 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05292885
Start Date
March 18 2022
End Date
December 1 2022
Last Update
March 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China, 266000